SCHEMBL1662883

SCHEMBL1662883

Cn1ccc(N)c1

nearest known ligand 0.00

⚠ Novel chemotype — no close known analogue (best Tanimoto < 0.3). Unexplored chemical space relative to ChEMBL.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
Hydrochloric Acid SCHEMBL1353327 0.97 — —
Iodide SCHEMBL27502072 0.97 — —
Ethoxycarbonyl Group SCHEMBL27604066 0.77 CA12 (0.32) —
SCHEMBL17678036 0.72 ALDH1A1 (0.50) —
SCHEMBL17233960 0.70 — —
SCHEMBL12447216 0.69 — —
SCHEMBL9809742 0.67 INMT (0.41) —
SCHEMBL19580288 0.65 — —
SCHEMBL12020327 0.65 — —
SCHEMBL811677 0.65 — —

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 165 patents — showing the first 20. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
WO-2024106781-A1 LIPID COMPOUND AND COMPOSITION FOR DELIVERY OF ACTIVE SUBSTANCE 한국생명공학연구원 2024-05-23 — — WO claimed
US-8486896-B2 Lipid tripeptide-based hydrogelator and hydrogel NISSAN CHEMICAL INDUSTRIES, LTD. (JP) 2013-07-16 — — US claimed
EP-2180027-B1 NOVEL LIPID-TRIPEPTIDE BASED HYDROGEL-FORMING AGENT AND HYDROGEL NISSAN CHEMICAL IND LTD (JP) 2011-10-26 — — EP claimed
US-20100279955-A1 NOVEL LIPID TRIPEPTIDE-BASED HYDROGELATOR AND HYDROGEL NISSAN CHEMICAL INDUSTRIES, LTD. (JP) 2010-11-04 — — US claimed
EP-2180027-A1 NOVEL LIPID-TRIPEPTIDE BASED HYDROGEL-FORMING AGENT AND HYDROGEL Nissan Chemical Industries, Ltd. (JP) 2010-04-28 — — EP claimed
US-12459925-B2 Sulphonyl urea derivatives as NLRP3 inflammasome modulators NodThera Limited (GB) 2025-11-04 — — US disclosed
EP-3728238-B1 SULPHONYL UREA DERIVATIVES AS NLRP3 INFLAMMASOME MODULATORS NODTHERA LTD (GB) 2025-06-18 — — EP disclosed
US-20240368129-A1 SULPHONYL UREA DERIVATIVES AS NLRP3 INFLAMMASOME MODULATORS NodThera Limited (GB) 2024-11-07 — — US disclosed
US-12025909-B2 Photoresponsive compound Konica Minolta, Inc. (JP) 2024-07-02 — — US disclosed
US-12012397-B2 Sulphonyl urea derivatives as NLRP3 inflammasome modulators NodThera Limited (GB) 2024-06-18 — — US disclosed
US-12006292-B2 Photoresponsive compound Konica Minolta, Inc. (JP) 2024-06-11 — — US disclosed
US-11994827-B2 Photoresponsive polymer Konica Minolta, Inc. (JP) 2024-05-28 — — US disclosed
EP-2180027-A1 NOVEL LIPID-TRIPEPTIDE BASED HYDROGEL-FORMING AGENT AND HYDROGEL Nissan Chemical Industries, Ltd. (JP) 2010-04-28 — — EP disclosed
US-20100048567-A1 Inhibitors of syk and JAK protein kinases PORTOLA PHARMACEUTICALS INC. (US) 2010-02-25 — — US disclosed
US-20100048567-A1 Inhibitors of syk and JAK protein kinases PORTOLA PHARMACEUTICALS INC. (US) 2010-02-25 — — US disclosed
CN-101605837-A Thermosetting composition HUNTSMAN ADV MAT SWITZERLAND (CH) 2009-12-16 — — CN disclosed
WO-2009136995-A2 INHIBITORS OF SYK PROTEIN KINASE PORTOLA PHARMACEUTICALS, INC. (US) 2009-11-12 — — WO disclosed
CN-101370765-A Method for selectively producing primary amine SUMITOMO CHEMICAL CO (JP) 2009-02-18 — — CN disclosed
EP-1847532-A1 IGF-1R INHIBITOR KYOWA HAKKO KOGYO CO., LTD. (JP) 2007-10-24 — — EP disclosed
WO-2007084786-A1 PYRIMIDINE DERIVATIVES USED AS PI-3 KINASE INHIBITORS NOVARTIS AG (CH) 2007-07-26 — — WO disclosed
Send feedback